13-May-2024
J.P. Morgan Remains a Buy on Taylor Morrison (TMHC)
TipRanks (Thu, 9-May 8:18 AM ET)
Taylor Morrison Reports First Quarter 2024 Results
PRNewswire (Tue, 30-Apr 6:15 AM ET)
Taylor Morrison Opens One of The Final New Build Communities in the Arvada Market
PRNewswire (Wed, 24-Apr 7:03 AM ET)
Taylor Morrison Announces Date for First Quarter 2024 Earnings Release and Webcast Conference Call
PRNewswire (Tue, 2-Apr 6:55 AM ET)
Taylor Morrison Ranked One of America's Most Responsible Companies by Newsweek
PRNewswire (Mon, 18-Mar 7:03 AM ET)
Taylor Morrison Sees 185% Increase in Women in Construction Roles Since 2019
PRNewswire (Tue, 5-Mar 6:03 AM ET)
Taylor Morrison Reports Fourth Quarter and Full Year 2023 Results
PRNewswire (Wed, 14-Feb 6:15 AM ET)
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West and Financial Services. The majority of the company's revenue is derived from its East Segment.
Taylor Morrison Home trades on the NYSE stock market under the symbol TMHC.
As of May 13, 2024, TMHC stock price declined to $59.27 with 497,249 million shares trading.
TMHC has a beta of 1.95, meaning it tends to be more sensitive to market movements. TMHC has a correlation of 0.59 to the broad based SPY ETF.
TMHC has a market cap of $6.27 billion. This is considered a Mid Cap stock.
Last quarter Taylor Morrison Home reported $2 billion in Revenue and $1.75 earnings per share. This beat revenue expectation by $60 million and exceeded earnings estimates by $.15.
In the last 3 years, TMHC stock traded as high as $62.64 and as low as $20.05.
The top ETF exchange traded funds that TMHC belongs to (by Net Assets): IJH, VTI, VB, IWM, VBR.
TMHC has outperformed the market in the last year with a price return of +36.1% while the SPY ETF gained +27.8%. TMHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.9% and +3.0%, respectively, while the SPY returned +4.3% and +2.5%, respectively.
TMHC support price is $58.27 and resistance is $60.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMHC stock will trade within this expected range on the day.